Navigation Links
Jennerex and Green Cross Announce Publication of Positive Clinical Data of JX-594 in Combination With Sorafenib in Advanced Liver Cancer
Date:4/20/2011

ial of JX-594 used as a single agent, will evaluate survival in advanced HCC patients who have progressed after treatment with sorafenib," stated David H. Kirn, M.D., president and chief executive officer of Jennerex.

"While the subset of patients in this trial is small, the data are quite compelling.  In prior studies we have demonstrated JX-594's ability to induce necrotic responses as a single agent. This is the first publication showing that JX-594 may sensitize tumors to subsequent treatment with VEGFR inhibitors, such as sorafenib," stated BG Rhee, Ph.D., president, Green Cross Corporation.

The publication also highlighted a case report of a complete and durable response in a patient with metastatic renal cell carcinoma (RCC) who received JX-594 in a Phase 1 intratumoral dose-escalation trial.  The patient, who had a baseline life expectancy of less than six months, had locally bulky and widely metastatic RCC.  The patient received four intratumoral injections of JX-594 and subsequently received standard therapy with sunitinib, an approved drug for RCC of the same class as sorafenib.  CT and PET scanning showed a whole-body complete response, and the patient remains alive and disease-free over four years after treatment initiation.  

About JX-594

JX-594 is a proprietary, engineered oncolytic virus that is designed to selectively target and destroy cancer cells. JX-594 is designed to attack cancer through three diverse mechanisms of action: the lysis of cancer cells through viral replication, the reduction of the blood supply to tumors through vascular targeting and destruction, and the stimulation of the body's immune response against cancer cells, i.e., active immunotherapy. Phase 1 and Phase 2 clinical trials in multiple cancer types to date have shown that JX-594, delivered either directly into tumors or systemically, induces tumor shrinkage and/or necrosis and is well-tolerated by patients. Object
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
2. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
3. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
4. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
5. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
6. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
7. Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma
8. Jennerex Announces Presentations at Upcoming Conferences
9. Jennerex Appoints Gregory W. Schafer as Chief Financial Officer
10. Jennerex Appoints Lara Longpre to Chief Operating Officer
11. Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... N.J. , Oct. 22, 2014  Quest Diagnostics ... of diagnostic information services, today announced that its Board ... serve as a director, effective December 1, 2014. Including ... Dr. Leiden is the Chairman, President and CEO of ... years of scientific and commercial experience in the pharmaceutical ...
(Date:10/22/2014)... RIDGE, N.J. , Oct. 22, 2014 /PRNewswire/ ... (RMANJ), a world-renowned leader in the field of ... rapid approach to embryonic screening. The research abstract, ... Society for Reproductive Medicine (ASRM) meeting in ... screening (CCS) and single gene defect (SGD) pre-implantation ...
(Date:10/22/2014)... October 22, 2014 A new ... Market (Product type, Form, End user, Application and Geography) ... Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - ... market. Based on key trends tracked, it is anticipated ... $7.9 billion by 2020, registering a CAGR of 6.2% ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4
... CIVCO Medical Solutions is showcasing its RFSuite RFID ... is also hosting an RFSuite Symposium Monday, August 1st, ... at the Fairmont Waterfront, Vancouver. The event will include ... Click here to view the invitation and register ...
... 20, 2011 CryoLife, Inc. (NYSE: CRY ), ... cardiac and vascular surgery, announced today that 2011 ... 28, 2011.  On that day, the Company will hold a ... to discuss the results, followed by a question and answer ...
Cached Medicine Technology:CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817 2CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817 3CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results 2
(Date:10/22/2014)... Hay House is pleased to announce the official release ... (Paperback; $10.82) written by the highly esteemed Tommy Rosen, leader ... is meant to help readers of all kinds end their ... Recovery 2.0 is not the average self-help book, or a ... for what comes next. For many, Alcoholics Anonymous ...
(Date:10/22/2014)... October 22, 2014 Best Cheap Hosting ... the world. The site has recently announced that iPower ... supplier for people from around the world. , “iPower ... operation today and is providing various kinds of useful ... company insists on offering excellent customer service and a ...
(Date:10/22/2014)... 22, 2014 Although there are only 24 hours ... many people who have trouble finding time within their busy schedules ... for long periods of time to get in shape. Here are ... on the go. , Change Up Your Commute , Consider ... to add some exercise into your daily routine. If you must ...
(Date:10/22/2014)... 22, 2014 Akeso Biomedical, Inc. ... the treatment of bacterial infections, microbial biofilms, and chronic ... its board of directors. , Dr. Sinskey ... at The Massachusetts Institute of Technology, or MIT. He ... 1968. Dr. Sinskey also holds positions as Co-Director of ...
(Date:10/22/2014)... sisters in high school have developed ways to measure ... use electronic stethoscopes, which electronically amplify body sounds, to ... heartbeats. Ilina, a senior at Port Huron Northern ... to detect early lung damage in people exposed to ... one breath cycle each from 16 smokers, 25 nonsmokers ...
Breaking Medicine News(10 mins):Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... ARLINGTON HEIGHTS, Ill. Using gene therapy, plastic surgeons ... on cancerous tumors on rats with a 79 percent ... the May issue of Plastic and Reconstructive Surgery, the ... Surgeons (ASPS). This new delivery technique, which has ...
... to Cover MLS Events;, Launches User-Generated Video Contest, Winning Entries to ... ... NEW YORK and LOS ANGELES, May 8 Juniper,Content Corporation,s (OTC Bulletin ... their,"Juega Como un MLS Pro" (translated "Play Like an MLS Pro") seven-month,joint ...
... may help to prevent osteoporosis later in life, research ... your teenage daughter to have strong bones? Steer her ... you may help her prevent low bone density later ... the combination of weight-bearing exercise and repetitive, "impact-loading" from ...
... Inc.,("GNC" or the "Company"), the largest global specialty ... for the first,quarter ended March 31, 2008., ... of GNC Parent LLC,which was acquired on March ... and Ontario Teachers, Pension Plan Board ("Teachers"). As ...
... Inc. (Nasdaq:,COWN) today announced its operating results for the quarter ... March 31, 2008 was $55.0 million,representing a decrease of 25% ... ended March 31, 2008, the Company reported net income of,$0.7 ... income of,$2.5 million in the prior year period, or $0.18 ...
... Regular daily activities can,expose us to hundreds of toxins ... the,common body care and household products we use. Toxicologists ... combined in the body and,have named this synergy the ... organ damage, can result., The May issue of ...
Cached Medicine News:Health News:Skin flaps deliver cancer-fighting therapy, ASPS study reveals 2Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 2Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 3Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 4Health News:Soccer's a Winner for Building Bone Health in Girls 2Health News:Soccer's a Winner for Building Bone Health in Girls 3Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 2Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 3Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 4Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 5Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 6Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 7Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 8Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 9Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 2Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 3Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 4Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 5Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 6Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 7Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 8Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 9Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 10Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 11Health News:Natural Solutions May Issue Illustrates 'Cocktail Effect' of Everyday Toxins; Offers Tips to Reduce Toxic Load 2
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
... These 3mL PYREX volumetric pipets ... tolerances in accordance with ASTM ... pipet is individually serialized and ... Identification and Capacity, traceable to ...
... action skin stapler with a ... designed to provide a clear ... your normal vantage point. Vista ... four configurations: 35 regular or ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
Medicine Products: